Kết quả tìm kiếm - D. Voliotis
- Đang hiển thị 1 - 4 kết quả của 4
-
1
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid... Bằng Dirk Strumberg, Heike Richly, Ralf A. Hilger, N. Schleucher, Sönke Korfee, Mitra Tewes, Markus Faghih, E. Brendel, D. Voliotis, Claus G. Haase, Brian Schwartz, Ahmad Awada, R. Voigtmann, M. E. Scheulen, S. Seeber
Được phát hành 2004Artigo -
2
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial Bằng Ann‐Lii Cheng, Zhongzhen Guan, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Tsai‐Sheng Yang, Won Young Tak, Hongming Pan, Shiying Yu, Jianming Xu, Fang Fang, J. Zou, Giuseppe Lentini, D. Voliotis, Yoon‐Koo Kang
Được phát hành 2012Artigo -
3
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial Bằng Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxı̀, Peter R. Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni, Camillo Porta, Guido Gerken, Jorge A. Marrero, Andrea Nadel, Michael Shan, M. Moscovici, D. Voliotis, Josep M. Llovet
Được phát hành 2012Artigo -
4
Sorafenib in Advanced Hepatocellular Carcinoma Bằng Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean Frédéric Blanc, André Cosme de Oliveira, Armando Santoro, Jean‐Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F. Greten, Peter R. Galle, Jean François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, M. Moscovici, D. Voliotis, Jordi Bruix
Được phát hành 2008Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Internal medicine
Medicine
Adverse effect
Gastroenterology
Hepatocellular carcinoma
Oncology
Sorafenib
Alternative medicine
Confidence interval
Hazard ratio
Pathology
Placebo
VEGF receptors
Vascular endothelial growth factor
Cancer research
Carcinoma
Environmental health
Pharmacokinetics
Pharmacology
Population
Randomized controlled trial
Subgroup analysis
Surgery
Toxicity